Urology · Maywood, NJ
NPI
1154390458
Since 2006
Specialty
Urology
Code 208800000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
255 W Spring Valley Ave, Suite #101
Maywood, NJ, 07607
Phone (201) 487-8866
Groups this clinician bills Medicare through
Medicare paid, 2024
$501K
9,337 services
Medicare patients, 2024
939
Average age 76
Drug cost, 2024
$588K
2,728 prescriptions
Company payments, 2025
$12K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael P Esposito was code 99213 (office e&m - established), 967 times for 644 patients. In total Michael P Esposito billed 9,337 services in 116 codes, and Medicare paid $501K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 967 | 644 | $70.18 | $68K |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 914 | 638 | $88.06 | $80K |
| 99214 Office E&M - Established | Office | 752 | 460 | $101.00 | $76K |
| 81002 Clinical Chemistry | Office | 452 | 314 | $3.39 | $1,535 |
| 36415 Venipuncture Blood Collection | Office | 417 | 292 | $8.55 | $3,565 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 203 | 33 | $140.11 | $28K |
| 99204 Office E&M - New | Office | 142 | 142 | $126.87 | $18K |
| 84153 Clinical Chemistry | Office | 122 | 117 | $18.02 | $2,198 |
| 76857 Ultrasound - Abdomen and Pelvis | Office | 119 | 112 | $30.44 | $3,622 |
| 51798 Ultrasound - Nonspecific | Office | 112 | 78 | $9.60 | $1,075 |
| 96402 Chemotherapy Administration | Office | 66 | 35 | $28.38 | $1,873 |
| 87086 Bacterial Culture | Office | 65 | 54 | $7.91 | $514 |
| 87088 Bacterial Culture | Office | 58 | 48 | $7.93 | $460 |
| J0690 Injection, cefazolin sodium, 500 mg | Office | 52 | 19 | $0.63 | $32.94 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 50 | 12 | $0.36 | $18.01 |
By year: 2022 $571K for 11,875 services; 2023 $497K for 9,316 services; 2024 $501K for 9,337 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 452 | 314 | $3.39 | $1,535 |
| 36415 Venipuncture Blood Collection | 417 | 292 | $8.55 | $3,565 |
| 84153 Clinical Chemistry | 122 | 117 | $18.02 | $2,198 |
| 87086 Bacterial Culture | 65 | 54 | $7.91 | $514 |
| 87088 Bacterial Culture | 58 | 48 | $7.93 | $460 |
| 87186 General Laboratory | 28 | 26 | $8.48 | $237 |
| 87077 Bacterial Culture | 28 | 26 | $7.92 | $222 |
| 82565 Clinical Chemistry | 22 | 22 | $4.81 | $106 |
| 84520 Clinical Chemistry | 19 | 19 | $3.68 | $69.96 |
| 80053 Clinical Chemistry | 14 | 14 | $10.35 | $145 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael P Esposito prescribed most often to Medicare patients was Finasteride, with 658 prescriptions and refills. In total Michael P Esposito wrote 2,728 Medicare prescriptions that cost $588K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Finasteride Generic | 658 | 1,898 | 199 | $13K |
| Tamsulosin Hcl Generic | 643 | 1,808 | 231 | $14K |
| Methenamine Hippurate Generic | 153 | 238 | 46 | $9,920 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 144 | 424 | 53 | $4,101 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 112 | 112 | 94 | $401 |
| Ciprofloxacin Hcl Generic | 71 | 71 | 57 | $353 |
| Dutasteride Generic | 67 | 202 | 21 | $3,612 |
| Solifenacin Succinate Generic | 67 | 177 | 27 | $2,936 |
| Silodosin Generic | 66 | 148 | 20 | $6,686 |
| Tadalafil Generic | 64 | 168 | 24 | $5,237 |
| Myrbetriq Mirabegron | 59 | 110 | 22 | $52K |
| Cephalexin Generic | 58 | 62 | 50 | $190 |
| Gemtesa Vibegron | 48 | 111 | 22 | $51K |
| Allopurinol Generic | 46 | 130 | 17 | $522 |
| Bethanechol Chloride Generic | 46 | 68 | 11 | $3,496 |
Brand drugs: - claims; generic drugs: 2,539 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael P Esposito $12K ($12K in general payments such as food, travel and fees) from 8 companies. The largest payer was Procept Biorobotics Corporation with $11K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.